iBio, Inc. (IBIO)

iBio, Inc. Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 6, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	79	12	18	10	58	329
Market Cap Growth	186.36%	-31.98%	77.58%	-82.21%	-82.49%	25.19%
Enterprise Value	32	12	31	22	37	258
Last Close Price	2.42	0.76	2.11	12.20	132.00	755.00
PS Ratio	64.17	30.94	80.87	-	30.57	138.74
PB Ratio	0.87	0.83	0.85	0.67	0.91	3.03
P/TBV Ratio	1.60	1.54	1.14	1.02	0.98	3.06
EV/Sales Ratio	64.95	29.35	137.12	-	19.52	108.69
Debt / Equity Ratio	0.06	0.24	0.23	1.14	0.41	0.30
Asset Turnover	0.01	0.02	0.01	-	0.02	0.02
Inventory Turnover	-	-	-	-	-	3.54
Quick Ratio	8.21	1.42	3.70	0.20	1.13	14.66
Current Ratio	8.40	1.59	4.08	1.19	1.48	15.74
Return on Equity (ROE)	-54.50%	-101.52%	-84.15%	-74.33%	-34.31%	-28.11%
Return on Assets (ROA)	-28.82%	-44.79%	-29.73%	-25.58%	-15.07%	-16.05%
Return on Capital Employed (ROCE)	-35.20%	-108.90%	-66.80%	-150.70%	-43.10%	-22.10%
Earnings Yield	-25.53%	-148.48%	-136.88%	-634.44%	-87.34%	-7.05%
FCF Yield	-21.97%	-123.78%	-103.12%	-359.78%	-77.80%	-10.63%
Buyback Yield / Dilution	-133.00%	-174.05%	-525.98%	-40.35%	-11.45%	-211.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q